New Horizons in MASH Management 

Join us for a symposium on metabolic dysfunction-associated steatohepatitis (MASH) designed to encourage the exchange of ideas between leaders in the field and attendees.<br />
<br />
<br />
Supported by:&nbsp;Inventivia<br />
<br />
Organized by: Medscape Education<br />
<br />
<br />
For more information and to register, visit:&nbsp;<a href="https://events.medscapelive.org/website/88600/">https://events.medscape… />
<br />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Summary of TERLIVAZ® (terlipressin): the first FDA-approved treatment for HRS in adults with rapid reduction in kidney function

The Summary of TERLIVAZ&reg; (terlipressin): the first FDA-approved treatment for HRS in adults with rapid reduction in kidney function. TLM theater will highlight the importance of early recognition and current diagnosis and treatment recommendations for hepatorenal syndrome&ndash;acute kidney injury (HRS-AKI).<br />
<br />
Industry Supporter:&nbsp;Mallinckrodt Pharmaceuticals

Advancing the Management of Cholestatic Liver Disease: Optimizing Treatment Pathways and Emerging Therapies

In this activity, experts in adult and paediatric hepatology and gastroenterology explore practical strategies and evidence-based tools to diagnose and facilitate tailored treatment decision-making for primary biliary cholangitis (PBC) and progressive familial intrahepatic cholestasis (PFIC).&nbsp;<br />
<br />
Supported by:&nbsp;Ipsen Biopharmaceuticals, Inc.&nbsp;<br />
<br />
Organized by:&nbsp;PeerVoice<br />
<br />
CME Provider: USF Health&nbsp;<br />
<br />
Link:&nbsp;<a href="https://cme.peervoice.com/140202451_1/140202451_1_p1/stage1reg?CountryI… />
<br />
Important Note: Continuing education credits for Satellite Symposia are offered by the sponsoring organizations. These sessions are not accredited by AASLD.

Science in the Park: How I Utilize Palliative Care

How do you study palliative care? Come discuss the science behind the recent Hepatology Communications article on the &ldquo;Surprise Question,&rdquo; a clinician-based prognostication tool initially developed to identify patients who may benefit from palliative care interventions with Dr. Nneka Ufere. Read the article here:&nbsp;<a href="https://journals.lww.com/hepcomm/fulltext/2025/08010/accuracy_of_the__s… />
&nbsp;<br />
12:45-12:55 PM- Presentation<br />
12:55-1:15 PM- Audience Q&amp;A and Discussion<br />
&nbsp;

Subscribe to